🇺🇸 FDA
Pipeline program

E7 TCR-T cells

192104

Phase 2 mab active

Quick answer

E7 TCR-T cells for HPV-Associated Cervical Carcinoma is a Phase 2 program (mab) at IOVANCE BIOTHERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
IOVANCE BIOTHERAPEUTICS, INC.
Indication
HPV-Associated Cervical Carcinoma
Phase
Phase 2
Modality
mab
Status
active

Clinical trials